Non-coding RNA-mediated high expression of SFXN3 as a prognostic biomarker associated with paclitaxel resistance and immunosuppressive microenvironment in head and neck cancer.
Chen K, Gong S, Fang X, Li Q, Ye M, Li J, Huang S, Zhao Y, Liu N, Li Y, et al. Front Immunol. 2022; 13:920136. Epub 2022 Sep 8.